Real-world First-line Sugemalimab-Chemotherapy in Advanced NSCLC

NCT07247227 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

NSCLC

Interventions

DRUG: Sugemalimab and Chemotherapy

Sponsor

Peking Union Medical College